HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 865619Erstellt: 24. Oktober 2026
1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → 6-(2',6'-Diaminohexanoylamino)-3,4,5-Trihydroxytetra-Hydropyran-2-ylmethyl 10,12-Tricosadiynoate
https://huagongshe.com/de/reaction/865619
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | 1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide | HCID 15908 | — |
| Edukt | 10,12-Tricosadiynoic Acid | HCID 538457 | — |
| Edukt | (2R,3R,4S,5R,6R)-2-Amino-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | HCID 11095207 | — |
| Edukt | Fmoc-Lys(Boc)-OPfp | HCID 11146634 | — |
| Lösungsmittel | Dimethylformamide | HCID 6228 | — |
| Produkt | 6-(2',6'-Diaminohexanoylamino)-3,4,5-Trihydroxytetra-Hydropyran-2-ylmethyl 10,12-Tricosadiynoate | HCID 18688966 | — |
Reaktionsschritte
1-Amino-1-deoxy-β-D-galactose (180 mg, 1 mmol), and Fmoc-Lys(Boc)-OPfp (650 mg, 1 mmol) were dissolved in 4 ml dry dimethylformamide and stirred at room temperature overnight. The solvent was removed in vacuo, the residue was redissolved in acetonitrile/water (1:1), filtered and purified by reversed phase chromatography (Lobar RPSB, acetonitrile/water 50:50 and 65:35). The relevant fractions were collected, concentrated in vacuo, and the product was characterised by NMR. The purified product (1 g, 1 mmol), 10,12-tricosadiynoic acid (350 mg, 1 mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide are dissolved in 10 ml dry dimethylformamide and stirred at room temperature overnight. The solvent is removed in vacuo, the residue redissolved in chloroform/methanol (95:5), filtered and purified by straight phase chromatography on a CHROMATOTRON. The relevant fractions are collected, concentrated in vacuo, and the product is characterised by NMR. The protecting groups of the α-ε amino groups are removed by standard reactions. Boc is removed by treatment with trifluoroacetic acid/methylene chloride for 30 minutes. The solvent is removed in vacuo. Fmoc is removed by treating the residue with 20% piperidine in dimethylformamide for 30 minutes, and the solvent is removed in vacuo. The final product is purified by reversed phase chromatography (Lobar RPSB).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US05567413 |
|---|
| Quelldatensatz | uspto-grants-1996_10 |
|---|
| ORD ID | ord-88e0b7008bdd4509972906eebe10c0a0 |
|---|
| Quellennotiz | uspto-grants-1996_10 |
|---|